Results 151 to 160 of about 83,211 (294)
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Moth-Eaten Pattern of Alopecia in Lichen Planopilaris. [PDF]
Clin Case RepJaiswal S +3 more
europepmc +1 more source
Children &Society, EarlyView.Abstract This article explores the ways in which ‘forest school’, an educational approach where children engage in creative and play based activities in a ‘natural’ environment, can contribute towards Sustainable Development Goal 15 (SDG 15) by promoting sustainable use of terrestrial ecosystems and by helping address biodiversity loss. Drawing on data
Hannah Hogarth
wiley +1 more source
Antibiotic resistance genes detected in lichens: insights from Cladonia stellaris. [PDF]
Ann BotAlonso-García M +5 more
europepmc +1 more source
Lichen flora of the eastern Mojave Desert: Blackrock Arizona, Mojave County, Arizona, USA
, 2005 Heather Bird Jackson +3 more
openalex +2 more sources
Clinical Oral Implants Research, EarlyView.ABSTRACT Introduction The aim was the immunohistological evaluation of a porcine dermal matrix (PDM) in comparison to a non‐augmented control group for peri‐implant tissue thickening. Materials and Methods This human histological study involved the placement of PDM in the test group (20 patients) during implant placement, while the control group ...
F. R. S. Michallek +9 more
wiley +1 more source
Stigmatization and bias in interpreting lichen sclerosus risk factors. [PDF]
Int J Womens DermatolParkinson SR, Corley SB.
europepmc +1 more source